Your browser doesn't support javascript.
loading
Cannabidiol para la epilepsia resistente a fármacos en Argentina: evaluación de tecnología sanitaria. Rev Argent Salud Püblica 2022; 14: e80. / Cannabidiol for drug-resistant epilepsy in Argentina: health technology assessment. Rev Argent Salud Pública. 2022; 14: e80.
Rodriguez, J.
  • Rodriguez, J; Hospital de Pediatría Prof. Dr. Juan P. Garrahan. Buenos Aires. AR
Med. infant ; 29(3): 261-264, Septiembre 2022.
Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1400796
Full text: Available Index: LILACS (Americas) Main subject: Technology Assessment, Biomedical / Drug Price / Cannabidiol / Pharmaceutical Preparations / Epilepsy Limits: Humans Country/Region as subject: South America / Argentina Language: Spanish Journal: Med. infant Year: 2022 Type: Article Institution/Affiliation country: Hospital de Pediatría Prof. Dr. Juan P. Garrahan/AR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Technology Assessment, Biomedical / Drug Price / Cannabidiol / Pharmaceutical Preparations / Epilepsy Limits: Humans Country/Region as subject: South America / Argentina Language: Spanish Journal: Med. infant Year: 2022 Type: Article Institution/Affiliation country: Hospital de Pediatría Prof. Dr. Juan P. Garrahan/AR